International Congress London 2016

Saturday, 03.09.2016 Sunday, 04.09.2016 Monday, 05.09.2016 Tuesday, 06.09.2016 Wednesday, 07.09.2016		Sponsored symposia: Industry Evening Mini Symposium at ERS 2016: “Challenges in the management of non-CF bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2016; 48: Suppl. 60, abstract number.

PG13 Inhaled antibiotics in respiratory infections

Postgraduate Course
Chairs: Aran Singanayagam (London, United Kingdom), Eva Polverino (Barcelona, Spain)
Aims: To provide an update on the use of inhaled antibiotics focusing on the evidence regarding their use in both acute and chronic respiratory infections; to delineate the areas of ongoing uncertainty and areas that require additional research.

How to access educational materials from mobile devices

Download all media

Programme PG13 Inhaled antibiotics in respiratory infections
Inhaled antibiotics: strengths and fears Lucy B. Palmer (New York, United States of America)
Inhaled antibiotics in cystic fibrosis: what we should do and what we still do not know Tobias Welte (Hannover, Germany)
Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics? Wim G. Boersma (Alkmaar, Netherlands)
Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis? Marcos I. Restrepo (San Antonio, United States of America)